Holger Wesche

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
EGFR binding proteins and methods of use
- Patent number 12,195,544
- Issue date Jan 14, 2025
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Constrained conditionally activated binding proteins
- Patent number 12,128,102
- Issue date Oct 29, 2024
- Takeda Pharmaceutical Company Limited
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 12,084,518
- Issue date Sep 10, 2024
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
B cell maturation antigen binding proteins
- Patent number 11,976,125
- Issue date May 7, 2024
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
DLL3 binding proteins and methods of use
- Patent number 11,807,692
- Issue date Nov 7, 2023
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mesothelin binding proteins
- Patent number 11,607,453
- Issue date Mar 21, 2023
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inducible monovalent antigen binding protein
- Patent number 11,535,668
- Issue date Dec 27, 2022
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 11,498,964
- Issue date Nov 15, 2022
- Amgen Research (Munich) GmbH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FLT3 binding proteins and methods of use
- Patent number 11,180,563
- Issue date Nov 23, 2021
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trispecific proteins and methods of use
- Patent number 11,136,403
- Issue date Oct 5, 2021
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,085,021
- Issue date Aug 10, 2021
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 10,954,311
- Issue date Mar 23, 2021
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
B cell maturation antigen binding proteins
- Patent number 10,927,180
- Issue date Feb 23, 2021
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prostate specific membrane antigen binding protein
- Patent number 10,849,973
- Issue date Dec 1, 2020
- HARPOON THERAPEUTICS, INC.
- Robert Dubridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PSMA targeting trispecific proteins and methods of use
- Patent number 10,844,134
- Issue date Nov 24, 2020
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
DLL3 binding proteins and methods of use
- Patent number 10,815,311
- Issue date Oct 27, 2020
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MSLN targeting trispecific proteins and methods of use
- Patent number 10,730,954
- Issue date Aug 4, 2020
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mesothelin binding proteins
- Patent number 10,543,271
- Issue date Jan 28, 2020
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 10,059,766
- Issue date Aug 28, 2018
- Amgen Inc.
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 9,708,412
- Issue date Jul 18, 2017
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IRAK-4: compositions and methods of use
- Patent number 7,235,635
- Issue date Jun 26, 2007
- Amgen Inc.
- Holger Wesche
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
NIK-knockout mice
- Patent number 6,822,138
- Issue date Nov 23, 2004
- Washington University in St. Louis
- Robert D. Schreiber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
IRAK-4: compositions and methods of use
- Patent number 6,818,419
- Issue date Nov 16, 2004
- Tularik Inc.
- Holger Wesche
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
CONDITIONAL ACTIVATION OF IMMUNOGLOBULIN MOLECULES
- Publication number 20240336909
- Publication date Oct 10, 2024
- Harpoon Therapeutics, Inc.
- Shuoyen Jack LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
B CELL MATURATION ANTIGEN BINDING PROTEINS
- Publication number 20240327534
- Publication date Oct 3, 2024
- Harpoon Therapeutics, Inc.
- Holger Wesche
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE
- Publication number 20240254250
- Publication date Aug 1, 2024
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EPCAM TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER
- Publication number 20240228656
- Publication date Jul 11, 2024
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DLL3 TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE
- Publication number 20240218063
- Publication date Jul 4, 2024
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EXTENDED-RELEASE IMMUNE CELL ENGAGING PROTEINS AND METHODS OF TREAT...
- Publication number 20240216518
- Publication date Jul 4, 2024
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DLL3 BINDING PROTEINS AND METHODS OF USE
- Publication number 20240141072
- Publication date May 2, 2024
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MESOTHELIN BINDING PROTEINS
- Publication number 20240100157
- Publication date Mar 28, 2024
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH IMMUNE CELL ENGAGING PROTEINS AND IMMUNOMO...
- Publication number 20240084035
- Publication date Mar 14, 2024
- Harpoon Therapeutics, Inc.
- Mary Ellen MOLLOY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody Constructs for CDH19 and CD3
- Publication number 20240010724
- Publication date Jan 11, 2024
- Amgen Inc.
- Shouhua Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EPCAM BINDING PROTEINS AND METHODS OF USE
- Publication number 20220267462
- Publication date Aug 25, 2022
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRISPECIFIC PROTEINS AND METHODS OF USE
- Publication number 20220112297
- Publication date Apr 14, 2022
- Harpoon Therapeutics, Inc.
- Holger Wesche
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FLT3 BINDING PROTEINS AND METHODS OF USE
- Publication number 20220098311
- Publication date Mar 31, 2022
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONDITIONALLY ACTIVE RECEPTORS
- Publication number 20220054544
- Publication date Feb 24, 2022
- Harpoon Therapeutics, Inc.
- Shuoyen Jack LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR BINDING PROTEINS AND METHODS OF USE
- Publication number 20220017626
- Publication date Jan 20, 2022
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDITIONALLY ACTIVATED TARGET-BINDING MOLECULES
- Publication number 20210355219
- Publication date Nov 18, 2021
- Harpoon Therapeutics, Inc.
- Shuoyen Jack LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOIETY FOR CONDITIONAL ACTIVATION OF IMMUNOGLOBULIN MOLECULES
- Publication number 20210292421
- Publication date Sep 23, 2021
- Harpoon Therapeutics, Inc.
- Shuoyen Jack LIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DUAL BINDING MOIETY
- Publication number 20210284728
- Publication date Sep 16, 2021
- Harpoon Therapeutics, Inc.
- Shuoyen Jack LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDITIONALLY ACTIVATED BINDING PROTEIN COMPRISING A STERICALLY OCC...
- Publication number 20210269530
- Publication date Sep 2, 2021
- Harpoon Therapeutics, Inc.
- Shuoyen Jack LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FLT3 BINDING PROTEINS AND METHODS OF USE
- Publication number 20210261671
- Publication date Aug 26, 2021
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRISPECIFIC BINDING PROTEINS AND METHODS OF USE
- Publication number 20210179735
- Publication date Jun 17, 2021
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
B CELL MATURATION ANTIGEN BINDING PROTEINS
- Publication number 20210171649
- Publication date Jun 10, 2021
- Harpoon Therapeutics, Inc.
- Holger Wesche
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN
- Publication number 20210100902
- Publication date Apr 8, 2021
- Harpoon Therapeutics, Inc.
- Robert DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA Targeting Trispecific Proteins and Methods of Use
- Publication number 20210095047
- Publication date Apr 1, 2021
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DLL3 BINDING PROTEINS AND METHODS OF USE
- Publication number 20210047439
- Publication date Feb 18, 2021
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MESOTHELIN BINDING PROTEINS
- Publication number 20200289646
- Publication date Sep 17, 2020
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MSLN TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE
- Publication number 20200270362
- Publication date Aug 27, 2020
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCIBLE MONOVALENT ANTIGEN BINDING PROTEIN
- Publication number 20200148771
- Publication date May 14, 2020
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPIES
- Publication number 20200115461
- Publication date Apr 16, 2020
- Harpoon Therapeutics, Inc.
- Luke EVNIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DLL3 BINDING PROTEINS AND METHODS OF USE
- Publication number 20200095340
- Publication date Mar 26, 2020
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- C07 - ORGANIC CHEMISTRY

Holger Wesche

Person

Patents Grantslast 30 patents

EGFR binding proteins and methods of use

Constrained conditionally activated binding proteins

Trispecific binding proteins and methods of use

B cell maturation antigen binding proteins

DLL3 binding proteins and methods of use

Mesothelin binding proteins

Inducible monovalent antigen binding protein

Antibody constructs for CDH19 and CD3

FLT3 binding proteins and methods of use

Trispecific proteins and methods of use

Compositions and methods for TCR reprogramming using fusion proteins

Trispecific binding proteins and methods of use

B cell maturation antigen binding proteins

Prostate specific membrane antigen binding protein

PSMA targeting trispecific proteins and methods of use

DLL3 binding proteins and methods of use

MSLN targeting trispecific proteins and methods of use

Mesothelin binding proteins

Antibody constructs for CDH19 and CD3

Trispecific binding proteins and methods of use

IRAK-4: compositions and methods of use

NIK-knockout mice

IRAK-4: compositions and methods of use

Patents Applicationslast 30 patents

CONDITIONAL ACTIVATION OF IMMUNOGLOBULIN MOLECULES

B CELL MATURATION ANTIGEN BINDING PROTEINS

BCMA TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE

EPCAM TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER

DLL3 TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE

EXTENDED-RELEASE IMMUNE CELL ENGAGING PROTEINS AND METHODS OF TREAT...

DLL3 BINDING PROTEINS AND METHODS OF USE

MESOTHELIN BINDING PROTEINS

COMBINATION THERAPY WITH IMMUNE CELL ENGAGING PROTEINS AND IMMUNOMO...

Antibody Constructs for CDH19 and CD3

EPCAM BINDING PROTEINS AND METHODS OF USE

TRISPECIFIC PROTEINS AND METHODS OF USE

FLT3 BINDING PROTEINS AND METHODS OF USE

CONDITIONALLY ACTIVE RECEPTORS

EGFR BINDING PROTEINS AND METHODS OF USE

CONDITIONALLY ACTIVATED TARGET-BINDING MOLECULES

BINDING MOIETY FOR CONDITIONAL ACTIVATION OF IMMUNOGLOBULIN MOLECULES

DUAL BINDING MOIETY

CONDITIONALLY ACTIVATED BINDING PROTEIN COMPRISING A STERICALLY OCC...

FLT3 BINDING PROTEINS AND METHODS OF USE

TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

B CELL MATURATION ANTIGEN BINDING PROTEINS

PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN

PSMA Targeting Trispecific Proteins and Methods of Use

DLL3 BINDING PROTEINS AND METHODS OF USE

MESOTHELIN BINDING PROTEINS

MSLN TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE

INDUCIBLE MONOVALENT ANTIGEN BINDING PROTEIN

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPIES

DLL3 BINDING PROTEINS AND METHODS OF USE